Full text is available at the source.
Abstract
Glucocorticoid treatment leads to cellular senescence in fibro-adipogenic progenitors (FAPs), contributing to muscle injury.
- Glucocorticoids are associated with muscle atrophy and dysfunction due to their impact on FAPs.
- The accumulation of senescent FAPs in skeletal muscle is linked to glucocorticoid exposure.
- Increased expression of GFPT2 through STAT5A is observed following glucocorticoid treatment, enhancing O-GlcNAcylation and promoting FAP senescence.
- Senescent FAPs derived from glucocorticoid treatment inhibit myotube formation, affecting skeletal muscle regrowth.
- These senescent FAPs may reduce the pool of muscle stem cells by inhibiting their proliferation, potentially impairing muscle recovery.
Simplified